Zusammenfassung
Die nekrotisierende Fasziitis gehört zu den komplizierten Weichgewebeinfektionen mit potentieller Lebensbedrohung. Trotz zunehmendem Erkenntnisgewinn in Bezug auf Ätiologie, Risikofaktoren und Pathophysiologie ist die Letalität mit ca. 20% hoch. Eine relevante Reduktion wird nur bei früher Diagnosestellung und konsequenter Therapie verzeichnet. Klinische Symptome sind in >75% der Patienten der disproportionale Schmerz, Schwellung, Ödem und Spannungsgefühl, Bläschenbildung und Rötung. Notwendig ist eine frühe Unterscheidung in eine nekrotisierende oder eine nichtnekrotisierende Weichgewebeinfektion. Bei unklarer Situation muss die chirurgische Exploration durchgeführt werden. Das pathologische Charakteristikum ist die verflüssigende Nekrose der Faszie, eine Vaskulitis und Thrombosen der lokalen Gefäße, die Ansammlung der verursachenden Mikroorganismen sowie mononukleärer Zellen und polymorphkerniger neutrophiler Granulozyten im Fasziengewebe. Sekundär können die Kutis sowie die Muskulatur befallen sein. In vielen Fällen besteht zwischen der Ausprägung systemischer und lokaler Symptome keine Beziehung. Es werden v. a. zwei Hauptformen unterschieden: die polymikrobielle Mischinfektion Typ I und die invasiver und in der Regel fulminanter verlaufende monomikrobielle Infektion Typ II (meist durch β-hämolysierende Streptokokken der Gruppe A).
Invasive, schwer verlaufende Streptokokkenerkrankungen scheinen in ihrer Häufigkeit zuzunehmen. Die Behandlung muss multimodal erfolgen und interdisziplinär ausgerichtet sein. Ihre Säulen sind das frühzeitige radikale Débridement, die breit angelegte, systemische Antibiotikatherapie und die Intensivtherapie, ggf. kombiniert mit einer Immunglobulin- (bei Strepto- oder Staphylokokkeninfektion) oder hyperbaren Sauerstofftherapie (HBO; bei Clostridienmischinfektion). Für die lokale Wundbehandlung der teilweise ausgedehnten Weichteildefekte bewährte sich die Vakuumversiegelung.
Abstract
Necrotizing fasciitis belongs to a group of complicated soft tissue infections that can be even life threatening. Despite growing knowledge about its etiology, predictors, and the clinical progression, the mortality remains at a high level with 20%. A relevant reduction can be achieved only by an early diagnosis followed by consistent therapy. The clinical findings in about 75% of the cases are pain out of proportion, edema and tenderness, blisters, and erythema. It is elementary to differentiate a necrotizing or a non-necrotizing soft tissue infection early. In uncertain cases it can be necessary to perform a surgical exploration to confirm the diagnosis. The histopathologic characteristics are the fascial necrosis, vasculitis, thrombosis of perforating veins, the presence of the disease-causing bacteria as well as inflammatory cells like macrophages and polymorphonuclear granulocytes. Secondly, both the cutis and the muscle can be affected. In many cases there is a disproportion of the degree of local and systemic symptoms. Depending on the infectious agents there are two main types: type I is a polymicrobial infection and type II is a more invasive, serious, and fulminant monomicrobial infection mostly caused by group A Streptococcus pyogenes.
Invasive, severe forms of streptococcal infections seem to occur more often in recent years. Multimodal and interdisciplinary therapy should be based on radical surgical débridement, systemic antibiotic therapy as well as enhanced intensive care therapy, which is sometimes combined with immunoglobulins (in streptococcal or staphylococcal infections) or hyperbaric oxygen therapy (HBOT, in clostridial infections). For wound care of extensive soft tissue defects vacuum-assisted closure has shown its benefit.
Literatur
(n a) (2001) Cellulitis. A spreading infection. Mayo Clin Health Lett 19:6
Anaya DA, Dellinger EP (2007) Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis 44:705–710
Baer W, Schaller P, Ruf S et al (2002) Diagnosis and therapy of necrotizing fasciitis. Orthopade 31:551–555
Bakleh M, Wold LE, Mandrekar JN et al (2005) Correlation of histopathologic findings with clinical outcome in necrotizing fasciitis. Clin Infect Dis 40:410–414
Barker FG, Leppard BJ, Seal DV (1987) Streptococcal necrotising fasciitis: comparison between histological and clinical features. J Clin Pathol 40:335–341
Beauchamp NJ Jr, Scott WW Jr, Gottlieb LM, Fishman EK (1995) CT evaluation of soft tissue and muscle infection and inflammation: a systematic compartmental approach. Skeletal Radiol 24:317–324
Bilton BD, Zibari GB, McMillan RW et al (1998) Aggressive surgical management of necrotizing fasciitis serves to decrease mortality: a retrospective study. Am Surg 64:397–400
Boyer A, Vargas F, Coste F et al (2009) Influence of surgical treatment timing on mortality from necrotizing soft tissue infections requiring intensive care management. Intensive Care Med 35:847–853
Brown CN, Pollard TC, Iyer S, Andrade AJ (2010) Invasive group A streptococcal infection: an update on the epidemiology and orthopaedic management. J Bone Joint Surg Br 92:763–769
Brun-Buisson C (2001) The therapeutic approach to necrotizing fasciitis. Ann Dermatol Venereol 128:394–403
Bryant AE, Bayer CR, Huntington JD, Stevens DL (2006) Group A streptococcal myonecrosis: increased vimentin expression after skeletal-muscle injury mediates the binding of Streptococcus pyogenes. J Infect Dis 193:1685–1692
Cainzos M, Gonzalez-Rodriguez FJ (2007) Necrotizing soft tissue infections. Curr Opin Crit Care 13:433–439
Casali RE, Tucker WE, Petrino RA et al (1980) Postoperative necrotizing fasciitis of the abdominal wall. Am J Surg 140:787–790
Childers BJ, Potyondy LD, Nachreiner R et al (2002) Necrotizing fasciitis: a fourteen-year retrospective study of 163 consecutive patients. Am Surg 68:109–116
Dale JB (2008) Current status of group A streptococcal infections. Adv Exp Med Biol 609:53–63
Darabi K, Abdel-Wahab O, Dzik WH (2006) Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature. Transfusion 46:741–753
Darenberg J, Jhenddyane N, Sjölin J et al (2003) Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: An European randomized double-blind placebo-controlled trial. Clin Infect Dis 37:333–340
Davies H, Mc Geer A (1996) Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med 335:547–554
Dellinger E (1981) Severe necrotizing soft tissue infection: multiple disease entities requiring a common approach. Jama 246:1717–1721
Descamps V, Aitken J, Lee MG (1994) Hippocrates on necrotising fasciitis. Lancet 344:556
Dworkin MS, Westercamp MD, Park L, McIntyre A (2009) The epidemiology of necrotizing fasciitis including factors associated with death and amputation. Epidemiol Infect 137:1609–1614
Edlich RF, Cross CL, Dahlstrom JJ, Long WB 3rd (2010) Modern concepts of the diagnosis and treatment of necrotizing fasciitis. J Emerg Med 39:261–265
Elliott D, Kufera JA, Myers RA (2000) The microbiology of necrotizing soft tissue infections. Am J Surg 179:361–366
Elliott DC, Kufera JA, Myers RA (1996) Necrotizing soft tissue infections. Risk factors for mortality and strategies for management. Ann Surg 224:672–683
Ellis Simonsen SM, Orman ER van, Hatch BE et al (2006) Cellulitis incidence in a defined population. Epidemiol Infect 134:293–299
Eter EG, Mneimeh W, Karam-Sarkis D et al (2009) Does Diclofenac increase the risc of cervical necrotising fasciitis in rat modell? Int J Exp Pathol 90:58-65
Flanagan CE, Daramola OO, Maisel RH et al (2009) Surgical debridement and adjunctive hyperbaric oxygen in cervical necrotizing fasciitis. Otolaryngol Head Neck Surg 140:730–734
Fournier JA (1883) Gangrene foudroyante de le verge. Semaine Medicale 3:345–348
Freeman HP, Oluwole SF, Ganepola GA, Dy E (1981) Necrotizing fasciitis. Am J Surg 142:377–383
Giuliano A, Lewis F Jr, Hadley K, Blaisdell FW (1977) Bacteriology of necrotizing fasciitis. Am J Surg 134:52–57
Hassan Z, Mullins RF, Friedman BC et al (2010) Treating necrotizing fasciitis with or without hyperbaric oxygen therapy. Undersea Hyperb Med 37:115–123
Haywood CT, McGeer A, Low DE (1999) Clinical experience with 20 cases of group A streptococcus necrotizing fasciitis and myonecrosis: 1995 to 1997. Plast Reconstr Surg 103:1567–1573
Hefny AF, Eid HO, Al-Hussona M et al (2007) Necrotizing fasciitis: a challenging diagnosis. Eur J Emerg Med 14:50–52
Hirn M (1993) Hyperbaric oxygen in the treatment of gas gangrene and perineal necrotizing fasciitis. A clinical and experimental study. Eur J Surg 570( Suppl):9-36
Hosek WT, Laeger TC (2009) Early diagnosis of necrotizing fasciitis with soft tissue ultrasound. Acad Emerg Med 16:1033
Howard RJ, Pessa ME, Brennaman BH, Ramphal R (1985) Necrotizing soft-tissue infections caused by marine vibrios. Surgery 98:126–130
Huang KC, Tu YK, Lee KF et al (2007) Disseminated cryptococcosis presented as necrotizing fasciitis of a limb. J Trauma 63:44–46
Huang WS, Hsieh SC, Hsieh CS et al (2006) Use of vacuum-assisted wound closure to manage limb wounds in patients suffering from acute necrotizing fasciitis. Asian J Surg 29:135–139
Institut Robert Koch (2000) Streptococcus pyogenes. Epidemiologisches Bulletin 43
Jallali N, Withey S, Butler PE (2005) Hyperbaric oxygen as adjuvant therapy in the management of necrotizing fasciitis. Am J Surg 189:462–466
Johansson L, Linner A, Sunden-Cullberg J et al (2009) Neutrophil-derived hyperresistinemia in severe acute streptococcal infections. J Immunol 183:4047–4054
Johansson L, Thulin P, Low DE, Norrby-Teglund A (2010) Getting under the skin: the immunopathogenesis of Streptococcus pyogenes deep tissue infections. Clin Infect Dis 51:58–65
Jones J (1871) Surgical memories of the war of the rebellion: investigation upon the nature, causes and treatment of hospital gangrene as prevailed in the federate armies. US Sanitary Commission, New York
Kawakami A, Saga K, Hida T et al (2006) Fulminant bowel-associated dermatosis-arthritis syndrome that clinically showed necrotizing fasciitis-like severe skin and systemic manifestations. J Eur Acad Dermatol Venereol 20:751–753
Khanna AK, Tiwary SK, Kumar P et al (2009) A case series describing 118 patients with lower limb necrotizing fasciitis. Int J Low Extrem Wounds 8:112–116
Klontz KC, Lieb S, Schreibver M et al (1988) Syndroms of Vibrio vulnificus infections. Clinical andepidemiological features in Florida cases, 1981–1987. Ann Intern Med 109:318–323
Korhonen K (2000) Hyperbaric oxygen therapy in acute necrotizing infections. With a special reference to the effects on tissue gas tensions. Ann Chir Gynaecol 89(Suppl 214):7–36
Krieg A, Rohrborn A, Schulte Am Esch J et al (2009) Necrotizing fasciitis: microbiological characteristics and predictors of postoperative outcome. Eur J Med Res 14:30–36
Lacy MD, Horn K (2009) Nosocomial transmission of invasive group a streptococcus from patient to health care worker. Clin Infect Dis 49:354–357
Lamagni TL, Darenberg J, Luca-Harari B et al (2008) Epidemiology of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 46:2359–2367
Lamothe F, D’Amico P, Ghosn P et al (1995) Clinical usefulness of intravenous human immunoglobulins in invasive group A Streptococcal infections: case report and review. Clin Infect Dis 21:1469–1470
Levenson RB, Singh AK, Novelline RA (2008) Fournier gangrene: role of imaging. Radiographics 28:519–528
Light TD, Choi KC, Thomsen TA et al (2010) Long-term outcomes of patients with necrotizing fasciitis. J Burn Care Res 31:93–99
Liu YM, Chi CY, Ho MW et al (2005) Microbiology and factors affecting mortality in necrotizing fasciitis. J Microbiol Immunol Infect 38:430–435
Loughnan BA, Grover M, Nielsen PB (2010) Maternal death due to extended spectrum beta-lactamase-producing E. coli: a warning for the future? Int J Obstet Anesth 19:327–330
Lovkvist L, Sjolinder H, Wehelie R et al (2008) CD46 contributes to the severity of group A streptococcal infection. Infect Immun 76:3951–3958
Luca-Harari B, Darenberg J, Neal S et al (2009) Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 47:1155–1165
Majeski JA, Alexander JW (1983) Early diagnosis, nutritional support, and immediate extensive debridement improve survival in necrotizing fasciitis. Am J Surg 145:784–787
Matsui H, Sekiya Y, Nakamura M et al (2009) CD46 transgenic mouse model of necrotizing fasciitis caused by Streptococcus pyogenes infection. Infect Immun 77:4806–4814
McHenry CR, Piotrowski JJ, Petrinic D, Malangoni MA (1995) Determinants of mortality for necrotizing soft-tissue infections. Ann Surg 221:558–563
Miller JD (1983) The importance of early diagnosis and surgical treatment of necrotizing fasciitis. Surg Gynecol Obstet 157:197–200
Miller LG, Perdreau-Remington F, Rieg G et al (2005) Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 352:1445–1453
Mok MY, Wong SY, Chan TM et al (2006) Necrotizing fasciitis in rheumatic diseases. Lupus 15:380–383
Morgan MS (2010) Diagnosis and management of necrotising fasciitis: a multiparametric approach. J Hosp Infect 75:249–257
Mulla ZD (2008) Hyperbaric oxygen in necrotizing fasciitis. Plast Reconstr Surg 122:1984–1985
Mulla ZD (2004) Treatment options in the management of necrotising fasciitis caused by Group A Streptococcus. Expert Opin Pharmacother 5:1695–1700
Nerlich A, Rohde M, Talay SR et al (2009) Invasion of endothelial cells by tissue-invasive M3 type group A streptococci requires Src kinase and activation of Rac1 by a phosphatidylinositol 3-kinase-independent mechanism. J Biol Chem 284:20319–20328
Norrby-Teglund A, Thulin P, Gan BS et al (2001) Evidence for superantigen involvement in severe group a streptococcal tissue infections. J Infect Dis 184:853–860
Nuwayhid ZB, Aronoff DM (2007) Blunt trauma as a risk factor for group A streptococcal necrotizing fasciitis. Ann Epidemiol 17(11):878–881
Olsen RJ, Musser JM (2010) Molecular pathogenesis of necrotizing fasciitis. Annu Rev Pathol 5:1–31
Piedra T, Martin-Cuesta L, Arnaiz J et al (2007) Necrotizing fasciitis secondary to diverticulitis. Emerg Radiol 13:345–348
Puvanendran R, Huey JC, Pasupathy S (2009) Necrotizing fasciitis. Can Fam Physician 55:981–987
Rahmouni A, Chosidow O, Mathieu D et al (1994) MR imaging in acute infectious cellulitis. Radiology 192:493–496
Ryssel H, Germann G, Czermak C et al (2010) Matriderm(R) in depth-adjusted reconstruction of necrotising fasciitis defects. Burns 36:1107–1111
Ryssel H, Germann G, Kloeters O et al (2010) Necrotizing fasciitis of the extremities: 34 cases at a single centre over the past 5 years. Arch Orthop Trauma Surg 130:1515–1522
Ryssel H, Germann G, Riedel K, Kollensperger E (2007) Surgical concept and results of necrotizing fasciitis. Chirurg 78:1123–1129
Saenz AJ, Koreishi AF, Rosenberg AE, Kradin RL (2009) Immune cell subsets in necrotizing fasciitis: an immunohistochemical analysis. Virchows Arch 455:87–92
Salcido RS (2007) Necrotizing fasciitis: reviewing the causes and treatment strategies. Adv Skin Wound Care 20:288–293
Sarani B, Strong M, Pascual J, Schwab CW (2009) Necrotizing fasciitis: current concepts and review of the literature. J Am Coll Surg 208:279–288
Sarkar B, Napolitano LM (2010) Necrotizing soft tissue infections. Minerva Chir 65:347–362
Schmid MR, Kossmann T, Duewell S (1998) Differentiation of necrotizing fasciitis and cellulitis using MR imaging. Am J Roentgenol 170:615–620
Schulze M, Overkamp D, Joanoviciu S, Horger M (2008) Necrotizing fasciitis: CT-imaging findings. Rofo 180:587–590
Seok JH, Jee WH, Chun KA et al (2009) Necrotizing fasciitis versus pyomyositis: discrimination with using MR imaging. Korean J Radiol 10:121–128
Silberstein J, Grabowski J, Parsons JK (2008) Use of a vacuum-assisted device for Fournier’s gangrene: A New Paradigm. Rev Urol 10:76–80
Singh G, Sinha SK, Adhikary S et al (2002) Necrotising infections of soft tissues – a clinical profile. Eur J Surg 168:366–371
Smeets L, Bous A, Heymans O (2007) Necrotizing fasciitis: case report and review of literature. Acta Chir Belg 107:29–36
Smeets L, Bous A, Lecoq J et al (2006) Necrotizing fasciitis: diagnosis and treatments. Rev Med Liege 61:240–244
Stamenkovic I, Lew PD (1984) Early recognition of potentially fatal necrotizing fasciitis. The use of frozen-section biopsy. N Engl J Med 310:1689–1693
Steinstraesser L, Sand M, Steinau HU (2009) Giant VAC in a patient with extensive necrotizing fasciitis. Int J Low Extrem Wounds 8:28–30
Stevens DL, Bisno AL, Chambers HF et al (2005) Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 41:1373–1406
Stevens DL, Eron LL (2009) Cellulitis and soft-tissue infections. Ann Intern Med 150
Su YC, Chen HW, Hong YC et al (2008) Laboratory risk indicator for necrotizing fasciitis score and the outcomes. ANZ J Surg 78:968–972
Sumi Y, Ogura H, Nakamori Y et al (2008) Nonoperative catheter management for cervical necrotizing fasciitis with and without descending necrotizing mediastinitis. Arch Otolaryngol Head Neck Surg 134:750–756
Tewodros W, Kronvall G (2005) M protein gene (emm type) analysis of group A beta-hemolytic streptococci from Etiopia reveals unique patterns. J Clin Microbiol 43:4369–4376
Thulin P, Johansson L, Low DE et al (2006) Viable group A streptococci in macrophages during acute soft tissue infection. PLoS Med 3:53
Tillou A, St Hill CR, Brown C, Velmahos G (2004) Necrotizing soft tissue infections: improved outcomes with modern care. Am Surg 70:841–844
Tsai YH, Huang TJ, Hsu RW et al (2009) Necrotizing soft-tissue infections and primary sepsis caused by Vibrio vulnificus and Vibrio cholerae non-O1. J Trauma 66:899–905
Umbert IJ, Winkelmann RK, Oliver GF, Peters MS (1989) Necrotizing fasciitis: a clinical, microbiologic, and histopathologic study of 14 patients. J Am Acad Dermatol 20:774–781
Wall DB, Virgilio C de, Black S, Klein SR (2000) Objective criteria may assist in distinguishing necrotizing fasciitis from nonnecrotizing soft tissue infection. Am J Surg 179:17–21
Wang TL, Hung CR (2004) Role of tissue oxygen saturation monitoring in diagnosing necrotizing fasciitis of the lower limbs. Ann Emerg Med 44:222–228
Wang YS, Wong CH, Tay YK (2007) Staging of necrotizing fasciitis based on the evolving cutaneous features. Int J Dermatol 46:1036–1041
Widjaja AB, Tran A, Cleland H et al (2005) The hospital costs of treating necrotizing fasciitis. ANZ J Surg 75:1059–1064
Wilson B (1952) Necrotizing fasciitis. Am Surg 18:416–431
Wong CH, Chang HC, Pasupathy S et al (2003) Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am 85:1454–1460
Wong CH, Khin LW, Heng KS et al (2004) The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med 32:1535–1541
Wong CH, Tan SH (2004) Subacute necrotising fasciitis. Lancet 364:1376
Wong CH, Yam AK, Tan AB, Song C (2008) Approach to debridement in necrotizing fasciitis. Am J Surg 196:19–24
Wysoki MG, Santora TA, Shah RM, Friedman AC (1997) Necrotizing fasciitis: CT characteristics. Radiology 203:859–863
Yen ZS, Wang HP, Ma HM et al (2002) Ultrasonographic screening of clinically-suspected necrotizing fasciitis. Acad Emerg Med 9:1448–1451
Yende S, Angus DC (2007) Long term outcomes from sepsis. Curr Infect Dis Rep 9:382–386
Yilmazlar T, Ozturk E, Alsoy A, Ozguc H (2007) Necrotizing soft tissue infections: APACHE II score, dissemination, and survival. World J Surg 31:1858–1862
Yoneda A, Fujita F, Tokai H et al (2010) MRI can determine the adequate area for debridement in the case of Fournier’s gangrene. Int Surg 95:76–79
Young LM, Price CS (2008) Community-acquired methicillin-resistant Staphylococcus aureus emerging as an important cause of necrotizing fasciitis. Surg Infect (Larchmt) 9:469–474
Yu JS, Habib P (2009) MR imaging of urgent inflammatory and infectious conditions affecting the soft tissues of the musculoskeletal system. Emerg Radiol 16:267–276
Zimbelman J, Palmer A, Todd J (1999) Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. Pediatr Infect Dis J 18:1096–1100
Karl T (2005) Fourniersches Gangrän auf dem Boden eines ischiorektalen Abszesses. In: Willy C (Hrsg) Die Vakuumtherapie – Grundlagen, Indikationen, Fallbeispiele, praktische Tipps. lindqvist book publishing, Ulm
Interessenskonflikt
Der korrespondierende Autor gibt an, dass kein Interessenskonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Herr, M., Grabein, B., Palm, HG. et al. Nekrotisierende Fasziitis. Unfallchirurg 114, 197–216 (2011). https://doi.org/10.1007/s00113-010-1893-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00113-010-1893-6
Schlüsselwörter
- Nekrotisierende Fasziitis
- Nekrotisierender Weichgewebeinfekt
- Streptokokken
- Vakuumversiegelung
- Wundbehandlung